Literature DB >> 7559621

Distinct isoforms of the CD45 protein-tyrosine phosphatase differentially regulate interleukin 2 secretion and activation signal pathways involving Vav in T cells.

D W McKenney1, H Onodera, L Gorman, T Mimura, D M Rothstein.   

Abstract

The CD45 family of transmembrane protein-tyrosine phosphatases plays a crucial role in the regulation of lymphocyte activation by coupling activation signals from antigen receptors to the signal transduction apparatus. Multiple CD45 isoforms, generated through regulated alternative mRNA splicing, differ only in the length and glycosylation of their extracellular domains. Differential distribution of these isoforms defines subsets of T cells having distinct functions and activation requirements. While the requirement for the intracellular protein-tyrosine phosphatase domains has been documented, the physiological role of the extracellular domains remains elusive. Here we report the generation of CD45-antisense transfected Jurkat T cell clones that lack CD45 or have been reconstituted to uniquely express either the smallest, CD45(0), or the largest, CD45(ABC), isoform. These cells exhibited marked isoform-dependent differences in IL-2 production and tyrosine phosphorylation of cellular proteins, including Vav after anti-CD3 stimulation. These results demonstrate that the distinct CD45 extracellular domains differentially regulate T cell receptor-mediated signaling pathways. Furthermore, these findings suggest that alterations in CD45 isoform expression by individual T cells during thymic ontogeny and after antigen exposure in the periphery directly affects the signaling pathways utilized.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7559621     DOI: 10.1074/jbc.270.42.24949

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Combinatorial effect of T-cell receptor ligation and CD45 isoform expression on the signaling contribution of the small GTPases Ras and Rap1.

Authors:  J Czyzyk; D Leitenberg; T Taylor; K Bottomly
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

2.  Analysis of Tn antigenicity with a panel of new IgM and IgG1 monoclonal antibodies raised against leukemic cells.

Authors:  Ola Blixt; Olga I Lavrova; Dmitriy V Mazurov; Emiliano Cló; Stjepan K Kracun; Nicolai V Bovin; Alexander V Filatov
Journal:  Glycobiology       Date:  2011-12-05       Impact factor: 4.313

3.  Epitope-specific crosslinking of CD45 down-regulates membrane-associated tyrosine phosphatase activity and triggers early signalling events in human activated T cells.

Authors:  François Spertini; Veronique Perret-Menoud; Nathalie Barbier; Talal Chatila; Catherine Barbey; Blaise Corthesy
Journal:  Immunology       Date:  2004-12       Impact factor: 7.397

Review 4.  CD45: all is not yet crystal clear.

Authors:  Nick Holmes
Journal:  Immunology       Date:  2006-02       Impact factor: 7.397

5.  A unique secreted adenovirus E3 protein binds to the leukocyte common antigen CD45 and modulates leukocyte functions.

Authors:  Mark Windheim; Jennifer H Southcombe; Elisabeth Kremmer; Lucy Chaplin; Doris Urlaub; Christine S Falk; Maren Claus; Janine Mihm; Myles Braithwaite; Kevin Dennehy; Harald Renz; Martina Sester; Carsten Watzl; Hans-Gerhard Burgert
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-11       Impact factor: 11.205

Review 6.  Regulation of cell signaling by the protein tyrosine phosphatases, CD45 and SHP-1.

Authors:  T Ulyanova; J Blasioli; M L Thomas
Journal:  Immunol Res       Date:  1997-02       Impact factor: 2.829

7.  CD43-independent augmentation of mouse T-cell function by glycoprotein cleaving enzymes.

Authors:  Scott B Berger; Amir A Sadighi Akha; Richard A Miller; Gonzalo G Garcia
Journal:  Immunology       Date:  2006-06-23       Impact factor: 7.397

8.  Protein phosphatase 2A is a negative regulator of IL-2 production in patients with systemic lupus erythematosus.

Authors:  Christina G Katsiari; Vasileios C Kyttaris; Yuang-Taung Juang; George C Tsokos
Journal:  J Clin Invest       Date:  2005-10-13       Impact factor: 14.808

9.  Antibody-mediated targeting of CD45 isoforms: a novel immunotherapeutic strategy.

Authors:  G P Basadonna; L Auersvald; C Q Khuong; X X Zheng; N Kashio; D Zekzer; M Minozzo; H Qian; L Visser; A Diepstra; A I Lazarovits; S Poppema; T B Strom; D M Rothstein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

10.  CD45-associated protein promotes the response of primary CD4 T cells to low-potency T-cell receptor (TCR) stimulation and facilitates CD45 association with CD3/TCR and lck.

Authors:  David Leitenberg; Rustom Falahati; Dan Dan Lu; Akiko Takeda
Journal:  Immunology       Date:  2007-04-12       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.